19 / 140
141
18. Greenland P; Alpert JS; Beller GA et al. 2010 ACCF/AHA Guideline for
Assesment of Cardiovascular Risk in Asyntomtic Adults: A Report from
the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines. J Am Coll Cardiol.
2010; 56:e50-103.
19. Ridker P.M; Wilson PW; Grundy SM. Should C-Reactive Protein
be Added to Metabolic Syndrome and to Assesment of Global
Cardiovascular Risk?. Circulation. 2004;109:2818-2825.
20. Berrington de Gonzales A;Mahesh M; Kim KP et al. Projected Cancer
Risks from Computed Tomographic Scans Performed in the Unites
States in 2007. Arch Inern Med. 2009;169(22):2071-2077.
21. Youssef G; Budoff J; Coronary Artery Calcium Scoring, What is
Anwsered and what Question Remain. Cardiovasc Diagn Ther.
2012;2(2):94-105n.
22. Yeboah Joseph; McClelland RL; Polonsky TS, et al. Comparaison of
Novel RiskMarkers for Improvement of Cardiovascular Risk Assesment
in Intermediate Risk Individuals. JAMA. 2012;308:788-795.
23. Kavousi M; Suzette E; Rutten JH et al. Evaluation of Newer Risk
Markers for Coronary Heart Disease Risk Classification. Ann Intern
Med. 2012;156:438-444.
24. Di Angelantonio E; Chowdhury R et al. B-Type Natriuretic Peptides
and Cardiovascular Risk Systematic Review and Meta-Analysis of 40
Prospective Studies. Circulation. 2009;120:2177-2187.
25. Saunders J; Nambi V et al. Cardiac Troponin T Measured by a Highly
Sensitive Assay Predicts Coronary Heart Disease, Heart Failure,
and Mortality in the Atherosclerosis Risk in Communities Study.
Circulation. 2011;123:1367-1376.
[MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR - Dr. David Doron R. y col.]